Tachibana M., Amato P., Sparman M., Gutierrez N. M., Tippner-Hedges R., Ma H., Kang E., Fulati A., Lee H. S., Sritanaudomchai H., Masterson K., Larson J., Eaton D., Sadler-Fredd K., Battaglia D., Lee D., Wu D., Jensen J., Patton P., Gokhale S., Stouffer R. L., Wolf D., Mitalipov S.Human embryonic stem cells derived by somatic cell nuclear transfer. (англ.) // Cell. — 2013. — Vol. 153, no. 6. — P. 1228—1238. — doi:10.1016/j.cell.2013.05.006. — PMID23683578. [исправить]
Wang, X., Qu, J., Li, J., He, H., Liu, Z., & Huan, Y. (2020). Epigenetic Reprogramming During Somatic Cell Nuclear Transfer: Recent Progress and Future Directions. Frontiers in Genetics, 11, 205. doi:10.3389/fgene.2020.00205PMC7093498
Malin, K., Witkowska-Piłaszewicz, O., & Papis, K. (2022). The many problems of somatic cell nuclear transfer in reproductive cloning of mammals. Theriogenology, 189, 246-254. PMID35809358doi:10.1016/j.theriogenology.2022.06.030
Hu, Y., Yang, Y., Tan, P. et al. (2022). Induction of mouse totipotent stem cells by a defined chemical cocktail. Nature doi:10.1038/s41586-022-04967-9
Hamazaki, N., Kyogoku, H., Araki, H. et al. (2020). Reconstitution of the oocyte transcriptional network with transcription factors. Nature 589(7841):264-269 PMID33328630doi:10.1038/s41586-020-3027-9
Phanstiel DH, Brumbaugh J, Wenger CD et al. & Coon JJ. (2011) Proteomic and phosphoproteomic comparison of human ES and iPS cells. Nat Methods.; 8(10): 821—827. doi:10.1038/nmeth.1699
Linzhao Cheng, Nancy F. Hansen, Ling Zhao, et al & P. Paul Liu (2012) Low Incidence of DNA Sequence Variation in Human Induced Pluripotent Stem Cells Generated by Nonintegrating Plasmid Expression Cell Stem Cell, 2012; 10 (3), 337—344 doi:10.1016/j.stem.2012.01.005
Choi, Jiho; Lee, Soohyun; Mallard, William; et al. (2015). A comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs. Nature Biotechnology 33: 1173—1181. doi:10.1038/nbt.3388
Shutova, M. V., Surdina, A. V., Ischenko, D. S., Naumov, V. A., Bogomazova, A. N., Vassina, E. M., … & Kiselev, S. L. (2016). An integrative analysis of reprogramming in human isogenic system identified a clone selection criterion. Cell Cycle, 15(7), 986—997. doi:10.1080/15384101.2016.1152425
Kunitomi, A., Yuasa, S., Sugiyama, F., Saito, Y., Seki, T., Kusumoto, D., … & Egashira, T. (2016). H1foo Has a Pivotal Role in Qualifying Induced Pluripotent Stem Cells. Stem cell reports. 6(6), 825—833 doi:10.1016/j.stemcr.2016.04.015
Kunitomi, A., Hirohata, R., Osawa, M., Washizu, K., Arreola, V., Saiki, N., ... & Yamanaka, S. (2024). H1FOO-DD promotes efficiency and uniformity in reprogramming to naive pluripotency. Stem Cell Reports. PMID38701780doi:10.1016/j.stemcr.2024.04.005
Yagi T, Kosakai A, Ito D, Okada Y, Akamatsu W, et al. (2012) Establishment of Induced Pluripotent Stem Cells from Centenarians for Neurodegenerative Disease Research. PLoS ONE 7(7): e41572 doi:10.1371/journal.pone.0041572
Milhavet, O., & Lemaitre, J. M. (2014). Senescent-Derived Pluripotent Stem Cells Are Able to Redifferentiate into Fully Rejuvenated Cells. In Tumor Dormancy, Quiescence, and Senescence, Volume 2 (pp. 265—276). Springer Netherlands. doi:10.1007/978-94-007-7726-2_25
Osamu Hashizume, Sakiko Ohnishi, Takayuki Mito, et al. & Jun-Ichi Hayashi (2015). Epigenetic regulation of the nuclear-coded GCAT and SHMT2 genes confers human age-associated mitochondrial respiration defects. Scientific Reports, 5, Article number: 10434 doi:10.1038/srep10434
Rohani, L., Johnson, A. A., Arnold, A. and Stolzing, A. (2014), The aging signature: a hallmark of induced pluripotent stem cells? Aging Cell, 13(1): 2-7. doi: 10.1111/acel.12182
Boheler, K. R., Bhattacharya, S., Kropp, E. M., Chuppa, S., Riordon, D. R., Bausch-Fluck, D., … & Gundry, R. L. (2014). A Human Pluripotent Stem Cell Surface N-Glycoproteome Resource Reveals Markers, Extracellular Epitopes, and Drug Targets. Stem Cell Reports. doi:10.1016/j.stemcr.2014.05.002
Julie Mathieu, Zhan Zhang, Angelique Nelson, et al. and Hannele Ruohola-Baker (2013) Hypoxia Induces Re-Entry of Committed Cells into Pluripotency. STEM CELLS doi: 10.1002/stem.1446
Yijie Geng, Yongfeng Zhao, Lisa Corinna Schuster, et al., (2015). A Chemical Biology Study of Human Pluripotent Stem Cells Unveils HSPA8 as a Key Regulator of Pluripotency. Stem Cell Reports DOI: https://dx.doi.org/10.1016/j.stemcr.2015.09.023
Zhang, J., Tian, X., Peng, C., Yan, C., Li, Y., Sun, M., … & Han, Y. (2018). Transplantation of CREG modified embryonic stem cells improves cardiac function after myocardial infarction in mice. Biochemical and biophysical research communications, 503(2), 482—489. doi:10.1016/j.bbrc.2018.04.160PMID29684345
Ohnishi, K., Semi, K., Yamamoto, T., Shimizu, M., Tanaka, A., Mitsunaga, K., … & Yamada, Y. (2014). Premature Termination of Reprogramming In Vivo Leads to Cancer Development through Altered Epigenetic Regulation. Cell, 156(4), 663—677. doi:10.1016/j.cell.2014.01.005
Shibata, H., Komura, S., Yamada, Y., Sankoda, N., Tanaka, A., Ukai, T., … & Yamada, Y. (2018). In vivo reprogramming drives Kras-induced cancer development. Nature communications, 9(1), 1-16. PMID29802314PMC5970190doi:10.1038/s41467-018-04449-5
Ocampo, A., Reddy, P., Martinez-Redondo, P., Platero-Luengo, A., Hatanaka, F., Hishida, T., … & Belmonte, J. C. I. (2016). In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell, 167(7), 1719—1733. PMID27984723PMC5679279doi:10.1016/j.cell.2016.11.052
Hishida, T., Yamamoto, M., Hishida-Nozaki, Y., Shao, C., Huang, L., Wang, C., … & Belmonte, J. C. I. (2022). In vivo partial cellular reprogramming enhances liver plasticity and regeneration. Cell Reports, 39(4), 110730. doi:10.1016/j.celrep.2022.110730
Grigorash B.B, van Essen D, Liang G, Grosse L, Emelyanov A, Kang Z, Korablev A, Kanzler B, Molina C, Lopez E, Demidov O.N, Garrido C, Liu F, Saccani S, Bulavin D.V. (2023). p16High senescence restricts cellular plasticity during somatic cell reprogramming. Nat Cell Biol. PMID37652981doi:10.1038/s41556-023-01214-9
Olova, N., Simpson, D. J., Marioni, R. E., & Chandra, T. (2019). Partial reprogramming induces a steady decline in epigenetic age before loss of somatic identity. Aging cell, 18(1), e12877. PMID30450724PMC6351826doi:10.1111/acel.12877
Gill, D., Parry, A., Santos, F., Hernando-Herraez, I., Stubbs, T. M., Milagre, I., & Reik, W. (2021). Multi-omic rejuvenation of human cells by maturation phase transient reprogramming. bioRxiv.doi:10.1101/2021.01.15.426786
Melendez, E., Chondronasiou, D., Mosteiro, L., Martínez de Villarreal, J., Fernández-Alfara, M., Lynch, C. J., … & Serrano, M. (2022). Natural killer cells act as an extrinsic barrier for in vivo reprogramming. Development, 149(8), dev200361. PMID35420133doi:10.1242/dev.200361
Kamaraj, U. S., Chen, J., Katwadi, K., Ouyang, J. F., Sun, Y. B. Y., Lim, Y. M., … & Rackham, O. J. (2020). EpiMogrify models H3K4me3 data to identify signaling molecules that improve cell fate control and maintenance. Cell Systems, 11(5), 509—522. PMID33038298doi:10.1016/j.cels.2020.09.004
Rukhlenko, O. S., Halasz, M., Rauch, N., Zhernovkov, V., Prince, T., Wynne, K., … & Kholodenko, B. N. (2022). Control of cell state transitions. Nature, 1-11. PMID36104561doi:10.1038/s41586-022-05194-y
Joung, J., Ma, S., Tay, T., Geiger-Schuller, K. R., Kirchgatterer, P. C., Verdine, V. K., ... & Zhang, F. (2023). A transcription factor atlas of directed differentiation. Cell, 186(1), 209-229. PMID36608654doi:10.1016/j.cell.2022.11.026
Koga, K., Wang, B., & Kaneko, S. (2020). Current status and future perspectives of HLA-edited induced pluripotent stem cells. Inflammation and Regeneration, 40(1), 23-29. doi:10.1186/s41232-020-00132-9PMC7528263PMID33014207
Di Stasi A., Tey S. K., Dotti G., Fujita Y., Kennedy-Nasser A., Martinez C., Straathof K., Liu E., Durett A. G., Grilley B., Liu H., Cruz C. R., Savoldo B., Gee A. P., Schindler J., Krance R. A., Heslop H. E., Spencer D. M., Rooney C. M., Brenner M. K.Inducible apoptosis as a safety switch for adoptive cell therapy. (англ.) // The New England journal of medicine. — 2011. — Vol. 365, no. 18. — P. 1673—1683. — doi:10.1056/NEJMoa1106152. — PMID22047558. [исправить]
Shi, Z. D., Tchao, J., Wu, L., & Carman, A. J. Precision installation of a highly efficient suicide gene safety switch in human induced pluripotent stem cells. Stem cells translational medicine. PMID32662231doi:10.1002/sctm.20-0007
Vidal, S. E., Polyzos, A., Chatterjee, K., Ee, L. S., Swanzey, E., Morales-Valencia, J., … & Stadtfeld, M. (2020). Context-dependent requirement of euchromatic histone methyltransferase activity during reprogramming to pluripotency. Stem cell reports, 15(6), 1233—1245. PMID32976761PMC7724475doi:10.1016/j.stemcr.2020.08.011
Deng, P., Yuan, Q., Cheng, Y., Li, J., Liu, Z., Liu, Y., … & Wang, C. Y. (2021). Loss of KDM4B exacerbates bone-fat imbalance and mesenchymal stromal cell exhaustion in skeletal aging. Cell Stem Cell. S1934-5909(21)00010-2 PMID33571444doi:10.1016/j.stem.2021.01.010
Wei J, Antony J, Meng F, MacLean P, Rhind R, Laible G, Oback B (2017) KDM4B‐mediated reduction of H3K9me3 and H3K36me3 levels improves somatic cell reprogramming into pluripotency. Sci Rep 7: 7514 PMID28790329PMC5548918doi:10.1038/s41598-017-06569-2
Cheloufi S., Elling U., Hopfgartner B., Jung Y. L., Murn J., Ninova M., Hubmann M., Badeaux A. I., Euong Ang C., Tenen D., Wesche D. J., Abazova N., Hogue M., Tasdemir N., Brumbaugh J., Rathert P., Jude J., Ferrari F., Blanco A., Fellner M., Wenzel D., Zinner M., Vidal S. E., Bell O., Stadtfeld M., Chang H. Y., Almouzni G., Lowe S. W., Rinn J., Wernig M., Aravin A., Shi Y., Park P. J., Penninger J. M., Zuber J., Hochedlinger K.The histone chaperone CAF-1 safeguards somatic cell identity. (англ.) // Nature. — 2015. — Vol. 528, no. 7581. — P. 218—224. — doi:10.1038/nature15749. — PMID26659182. [исправить]
Rais Y., Zviran A., Geula S., Gafni O., Chomsky E., Viukov S., Mansour A. A., Caspi I., Krupalnik V., Zerbib M., Maza I., Mor N., Baran D., Weinberger L., Jaitin D. A., Lara-Astiaso D., Blecher-Gonen R., Shipony Z., Mukamel Z., Hagai T., Gilad S., Amann-Zalcenstein D., Tanay A., Amit I., Novershtern N., Hanna J. H.Deterministic direct reprogramming of somatic cells to pluripotency. (англ.) // Nature. — 2013. — Vol. 502, no. 7469. — P. 65—70. — doi:10.1038/nature12587. — PMID24048479. [исправить]
Hu, X., Wu, Q., Zhang, J., Kim, J., Chen, X., Hartman, A. A., … & Guo, S. (2021). Reprogramming progressive cells display low CAG promoter activity. STEM CELLS, 39(1), 43-54. PMID33075202PMC7821215doi:10.1002/stem.3295
Esteban, M. A., Wang, T., Qin, B., Yang, J., Qin, D., Cai, J., ... & Pei, D. (2010). Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell stem cell, 6(1), 71-79. PMID20036631doi:10.1016/j.stem.2009.12.001
Pavlovic, V., Ciric, M., Petkovic, M., & Golubovic, M. (2023). Vitamin C and epigenetics: A short physiological overview. Open Medicine, 18(1), 20230688. ((PMID|37359134}} PMC10290282doi:10.1515/med-2023-0688
Zimmerlin, L., Park, T. S., Huo, J. S., Verma, K., Pather, S. R., Talbot, C. C., … & Guo, H. (2016). Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality. Development, 143(23), 4368-4380. doi:10.1242/dev.138982PMC5201042
Jun Wu, Daiji Okamura, Mo Li, et al., & Juan Carlos Izpisua Belmonte (2015). An alternative pluripotent state confers interspecies chimaeric competency. Nature, doi:10.1038/nature14413
Li Qian, Yu Huang, C. Ian Spencer, Amy Foley, Vasanth Vedantham, Lei Liu, Simon J. Conway, Ji-dong Fu & Deepak Srivastava. (2012) In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature, Nature; 485, 593—598. doi:10.1038/nature11044
Eva Szabo, et al & Mickie Bhatia (2010) Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 468, 521—526 PMID21057492doi:10.1038/nature09591
Jem A. Efe, et al & Sheng Ding (2011) Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy Nature Cell Biology 13, 215—222 PMID21278734doi:10.1038/ncb2164
Thomas Vierbuchen and Marius Wernig (2011) Direct Lineage Conversions: Unnatural but useful? Nat Biotechnol.; 29(10): 892—907. doi:10.1038/nbt.1946.
Han D.W., Tapia N., Hermann A., et al. & Schöler H.R. Direct Reprogramming of Fibroblasts into Neural Stem Cells by Defined Factors.Stem Cells Dev. 2012 Mar 1;21(4):521-9. PMID22445517doi:10.1016/j.stem.2012.02.021
Prasad A, Boon Loong Teh D, Shah Jahan FR, Manivannan J, Chua SM, and All AH (2016). Direct Conversion through Trans-differentiation: Efficacy and Safety. Stem Cells and Development., doi:10.1089/scd.2016.0174.
Horisawa, K., & Suzuki, A. (2020). Direct cell-fate conversion of somatic cells: Toward regenerative medicine and industries. Proceedings of the Japan Academy. Series B, Physical and Biological Sciences, 96(4), 131—158. doi:10.2183/pjab.96.012PMC7247973PMID32281550
Giurumescu, C. A., & Chisholm, A. D. (2011). Cell Identification and Cell Lineage Analysis. Caenorhabditis Elegans: Molecular Genetics and Development, 106, 323—341 https://dx.doi.org/10.1016/B978-0-12-544172-8.00012-8
Hiroshi Kurosawa (2012) Application of Rho-associated protein kinase (ROCK) inhibitor to human pluripotent stem cells. Journal of Bioscience and Bioengineering, 114(6), 577—581 doi:10.1016/j.jbiosc.2012.07.013
Xuefeng Liu, Virginie Ory, Sandra Chapman, et al. & Richard Schlegel (2012) ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells. The American Journal of Pathology, 180(2), 599—607 doi:10.1016/j.ajpath.2011.10.036
Seema Agarwal, David L. Rimm (2012) Making Every Cell Like HeLa: A Giant Step For Cell Culture. The American Journal of Pathology, 180(2), 443—445 doi:10.1016/j.ajpath.2011.12.001
Yann Barrandon, Nicolas Grasset, Andrea Zaffalon, et al. & Ariane Rochat (2012) Capturing epidermal stemness for regenerative medicine. Seminars in Cell & Developmental Biology. 23(8), 937—944 doi:10.1016/j.semcdb.2012.09.011
Wu, X., Wang, S., Li, M., Li, J., Shen, J., Zhao, Y., … & Kaboli, P. J. (2020). Conditional reprogramming: next generation cell culture. Acta Pharmaceutica Sinica B. 10(8), 1360—1381 doi:10.1016/j.apsb.2020.01.011
Soto-Pantoja, D. R., Ridnour, L. A., Wink, D. A. & Roberts, D. D. (2013) Blockade of CD47 increases survival of mice exposed to lethal total body irradiation. Sci Rep 3, 1038 doi:10.1038/srep01038
Zhang, X., Stojkovic, P., Przyborski, S.,et al. and Stojkovic, M. (2006), Derivation of Human Embryonic Stem Cells from Developing and Arrested Embryos. STEM CELLS, 24: 2669—2676. doi:10.1634/stemcells.2006-0377
Tateno, H., Matsushima, A., Hiemori, K., et al., & Hirabayashi, J. (2013). Podocalyxin is a glycoprotein ligand of the human pluripotent stem cell-specific probe rBC2LCN. Stem cells translational medicine, 2(4), 265—273. doi:10.5966/sctm.2012-0154
Suila Heli, Hirvonen Tia, Ritamo Ilja, et al. and Valmu Leena. (2014). Extracellular O-Linked N-Acetylglucosamine Is Enriched in Stem Cells Derived from Human Umbilical Cord Blood. BioResearch, 3(2): 39-44. doi:10.1089/biores.2013.0050.
Perdigoto, C. N., & Bardin, A. J. (2013). Sending the right signal: Notch and stem cells. Biochimica et Biophysica Acta (BBA)-General Subjects, 1830(2), 2307—2322. https://dx.doi.org/10.1016/j.bbagen.2012.08.009
Jafar-Nejad, H., Leonardi, J., & Fernandez-Valdivia, R. (2010). Role of glycans and glycosyltransferases in the regulation of Notch signaling. Glycobiology, 20(8), 931—949. doi:10.1093/glycob/cwq053
Frederico Alisson-Silva, Deivid de Carvalho Rodrigues, Leandro Vairo, et al. and Adriane R Todeschini (2014). Evidences for the involvement of cell surface glycans in stem cell pluripotency and differentiation. Glycobiology 24 (5): 458—468.
doi:10.1093/glycob/cwu012
Hasehira, K., Tateno, H., Onuma, Y., Ito, Y., Asashima, M., & Hirabayashi, J. (2012). Structural and Quantitative Evidence for Dynamic Glycome Shift on Production of Induced Pluripotent Stem Cells. Molecular & Cellular Proteomics,11(12), 1913—1923. doi:10.1074/mcp.M112.020586
Becker-Kojic, Z. A., & Terness, P. (2002). A novel human erythrocyte GPI anchored glycoprotein ACA. Isolation, purification, primary structure determination, molecular parameters of its lipid structure. . Journal of Biological Chemistry, 277, 40472-40478. doi:10.1074/jbc.M202416200
Zheng, Z., Jian, J., Zhang, X., Zara, J. N., Yin, W., Chiang, M., … & Soo, C. (2012). Reprogramming of human fibroblasts into multipotent cells with a single ECM proteoglycan, fibromodulin. Biomaterials, 33(24), 5821-5831. PMID22622142doi:10.1016/j.biomaterials.2012.04.049
Zheng, Z., Li, C., Ha, P., Chang, G. X., Yang, P., Zhang, X., … & Mills, Z. (2019). CDKN2B upregulation prevents teratoma formation in multipotent fibromodulin-reprogrammed cells. Journal of Clinical Investigation, 129(8), 3236-3251. doi:10.1172/JCI125015PMC6668700PMID31305260
Bedzhov, I., Alotaibi, H., Basilicata, M. F. et al.., & Stemmler, M. P. (2013). Adhesion, but not a specific cadherin code, is indispensable for ES cell and induced pluripotency. Stem cell research, 11(3), 1250—1263 https://dx.doi.org/10.1016/j.scr.2013.08.009.
Guannan Su, Yannan Zhao, Jianshu Wei, et al. & Jianwu Dai (2013) Direct conversion of fibroblasts into neural progenitor-like cells by forced growth into 3D spheres on low attachment surfaces. Biomaterials, 34(24), 5897-5906 doi:10.1016/j.biomaterials.2013.04.040
Nath S. C., Day B., Harper L., et al., & Rancourt D. E. (2021). Fluid Shear Stress Promotes Embryonic Stem Cell Pluripotency via Interplay between β‐catenin and Vinculin in Bioreactor Culture. Stem Cells, doi:10.1002/stem.3382
Timothy L. Downing, Jennifer Soto, Constant Morez, Timothee Houssin, Ashley Fritz, Falei Yuan, Julia Chu, Shyam Patel, David V. Schaffer, Song Li. Biophysical regulation of epigenetic state and cell reprogramming. Nature Materials, 2013; doi:10.1038/nmat3777
Yubing Sun, Koh Meng Aw Yong, Luis G. Villa-Diaz, et al. & Jianping Fu(2014). Hippo/YAP-mediated rigidity-dependent motor neuron differentiation of human pluripotent stem cells. Nature Materials doi:10.1038/nmat3945
Massimiliano Caiazzo, Yuya Okawa, Adrian Ranga, Alessandra Piersigilli, Yoji Tabata, Matthias P. Lutolf (2016). Defined three-dimensional microenvironments boost induction of pluripotency. Nature Materials, doi:10.1038/nmat4536
Roy, B., Yuan, L., Lee, Y., Bharti, A., Mitra, A., & Shivashankar, G. V. (2020). Fibroblast rejuvenation by mechanical reprogramming and redifferentiation. Proceedings of the National Academy of Sciences, 117(19), 10131-10141 doi:10.1073/pnas.1911497117PMC7229653PMID32350144
Ankur Singh, Shalu Suri, Ted Lee, et al. & Andrés J García (2013). Adhesion strength-based, label-free isolation of human pluripotent stem cells. Nature Methods, 10, 438—444 doi:10.1038/nmeth.2437
Eva C. Thomaemail, Claudia Merkl, Tobias Heckel, Rachel Haab, Frederic Knoflach, Corinne Nowaczyk, Nicholas Flint, Ravi Jagasia, Sannah Jensen Zoffmann, Hoa Hue Truong, Pascal Petitjean, Sebastian Jessberger, Martin Graf, Roberto Iacone(2014). Chemical Conversion of Human Fibroblasts into Functional Schwann Cells. Stem Cell Reports, 3(4), 539—547, DOI: https://dx.doi.org/10.1016/j.stemcr.2014.07.014
Wenze Niu, Tong Zang, Yuhua Zou, Sanhua Fang, Derek K. Smith, Robert Bachoo, Chun-Li Zhang. In vivo reprogramming of astrocytes to neuroblasts in the adult brain. Nature Cell Biology, 2013; 15 (10): 1164 doi:10.1038/ncb2843
Zhida Su, Wenze Niu, Meng-Lu Liu, Yuhua Zou, Chun-Li Zhang. In vivo conversion of astrocytes to neurons in the injured adult spinal cord. Nature Communications, 2014; 5 doi:10.1038/ncomms4338
Liu G-H, Yi F, Suzuki K, Qu J. and Izpisua Belmonte J C. (2012) Induced neural stem cells: a new tool for studying neural development and neurological disorders. Cell Research 22, 1087—1091. doi:10.1038/cr.2012.73
Nan Cao, Yu Huang, Jiashun Zheng et al & Deepak Srivastava, Sheng Ding (2016). Conversion of human fibroblasts into functional cardiomyocytes by small molecules. Science, doi:10.1126/science.aaf1502
Pushp, P., Nogueira, D. E., Rodrigues, C. A., Ferreira, F. C., Cabral, J. M., & Gupta, M. K. (2020). A Concise Review on Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Personalized Regenerative Medicine. Stem Cell Reviews and Reports, 1-29. PMID33098306doi:10.1007/s12015-020-10061-22
Benjamin D Cosgrove, Penney M Gilbert, Ermelinda Porpiglia et al. & Helen M Blau (Feb. 2014). Rejuvenation of the muscle stem cell population restores strength to injured aged muscles. Nature Medicine, doi:10.1038/nm.3464
Hosoyama, et al. and Masatoshi Suzuki (March, 2014). Derivation of Myogenic Progenitors Directly From Human Pluripotent Stem Cells Using a Sphere-Based Culture. Stem Cells Trans Med. doi:10.5966/sctm.2013-0143
Huang, P., Zhang, L., Gao, Y., He, Z., Yao, D., Wu, Z., … & Hui, L. (2014). Direct Reprogramming of Human Fibroblasts to Functional and Expandable Hepatocytes. Cell stem cell, 14(3), 370—384. doi:10.1016/j.stem.2014.01.003
Miyajima, A., Tanaka, M., & Itoh, T. (2014). Stem/Progenitor Cells in Liver Development, Homeostasis, Regeneration, and Reprogramming. Cell Stem Cell, 14(5), 561—574. DOI: https://dx.doi.org/10.1016/j.stem.2014.04.010
Saiyong Zhu, Holger A. Russ, Xiaojing Wang, Mingliang Zhang, Tianhua Ma, Tao Xu, Shibing Tang, Matthias Hebrok, Sheng Ding. Human pancreatic beta-like cells converted from fibroblasts. Nature Communications, 2016; 7: 10080 doi:10.1038/ncomms10080
Abdelalim, E. M., Bonnefond, A., Bennaceur-Griscelli, A., & Froguel, P. (2014). Pluripotent Stem Cells as a Potential Tool for Disease Modelling and Cell Therapy in Diabetes. Stem Cell Reviews and Reports, 1-11. doi:10.1007/s12015-014-9503-6
Hrvatin, S., O’Donnell, C. W., Deng, F., et al. & Melton, D. A. (2014). Differentiated human stem cells resemble fetal, not adult, β cells. Proceedings of the National Academy of Sciences, 111(8), 3038-3043. doi:10.1073/pnas.1400709111
Chen, Y. J., Finkbeiner, S. R., Weinblatt, D., et al. & Stanger, B. Z. (2014). De Novo Formation of Insulin-Producing «Neo-β Cell Islets» from Intestinal Crypts. Cell Reports., doi:10.1016/j.celrep.2014.02.013
Pereira, C. F., Chang, B., Qiu, J., Niu, X., Papatsenko, D., Hendry, C. E., … & Moore, K. (2013). Induction of a hemogenic program in mouse fibroblasts. Cell stem cell, 13(2), 205—218. DOI: https://dx.doi.org/10.1016/j.stem.2013.05.024
Jonah Riddell, Roi Gazit, Brian S. Garrison, et al., & Derrick J. Rossi (2014). Reprogramming Committed Murine Blood Cells to Induced Hematopoietic Stem Cells with Defined Factors. Cell, 157(30, 549—564, DOI: https://dx.doi.org/10.1016/j.cell.2014.04.006
Rousseau, G. F., Mazurier, C. and Douay, L. (2016), Culturing red blood cells from stem cells: a solution to present and future challenges of transfusion medicine?. ISBT Science Series, 11: 111—117. doi:10.1111/voxs.12235
Giani, F. C., Fiorini, C., Wakabayashi, A., Ludwig, L. S., Salem, R. M., Jobaliya, C. D., … & Guo, M. H. (2016). Targeted Application of Human Genetic Variation Can Improve Red Blood Cell Production from Stem Cells. Cell stem cell, 18(1), 73-78 doi:10.1016/j.stem.2015.09.015
Stanford, E. A., Wang, Z., Novikov, O., Mulas, F., Landesman-Bollag, E., Monti, S., … & Sherr, D. H. (2016). The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells. BMC biology, 14(1), 1. doi:10.1186/s12915-016-0240-y
Brenden W. Smith, Sarah S. Rozelle, Amy Leung, et al and George J. Murphy (2013) The aryl hydrocarbon receptor directs hematopoietic progenitor cell expansion and differentiation. Blood, blood-2012-11-466722, doi:10.1182/blood-2012-11-466722
Mao, B., Lu, X., Huang, S., Yu, J., Lai, M., Tsuji, K., … & Ma, F. (2015). Derivation of Mature Erythrocytes from Human Pluripotent Stem Cells by Coculture with Murine Fetal Stromal Cells. In Hematopoietic Differentiation of Human Pluripotent Stem Cells (pp. 15-39). Springer Netherlands. doi:10.1007/978-94-017-7312-6_2
Fujita, A., Uchida, N., Haro-Mora, J. J., Winkler, T. and Tisdale, J. (2016), β-Globin-Expressing Definitive Erythroid Progenitor Cells Generated from Embryonic and Induced Pluripotent Stem Cell-Derived Sacs. STEM CELLS. doi:10.1002/stem.2335
Suzuki, D., Flahou, C., Yoshikawa, N., Stirblyte, I., Hayashi, Y., Sawaguchi, A., … & Matsumoto, T. (2020). «iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity». Stem cell reports, 14(1), 49-59. doi:10.1016/j.stemcr.2019.11.011PMC6962657PMID31883921
Nurhayati, R. W., Ojima, Y., & Taya, M. (2016). Recent developments in ex vivo platelet production. Cytotechnology, 1-11. doi:10.1007/s10616-016-9963-4
Raul Vizcardo, Kyoko Masuda, Daisuke Yamada, et al. & Hiroshi Kawamoto (2013) Regeneration of Human Tumor Antigen-Specific T Cells from iPSCs Derived from Mature CD8+ T Cells . Cell Stem Cell, 12(1), 31-36 DOI: doi:10.1016/j.stem.2012.12.006
Woan K.V., Kim H., Bjordahl R., et al. (2021). Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy. Cell Stem Cell, In Press, doi:10.1016/j.stem.2021.08.013
Rapino F., et al., & Graf T. (2013) C/EBPaInduces Highly Efficient Macrophage Transdifferentiation of B Lymphoma and Leukemia Cell Lines and Impairs Their Tumorigenicity, Cell Reports https://dx.doi.org/10.1016/j.celrep.2013.03.003
Guo, J., Feng, Y., Barnes, P., Huang, F. F., Idell, S., Su, D. M., & Shams, H. (2012). Deletion of FoxN1 in the thymic medullary epithelium reduces peripheral T cell responses to infection and mimics changes of aging. PloS one, 7(4), e34681. doi:10.1371/journal.pone.0034681
Poloni A, Maurizi G, Leoni P, et al. & Cinti S (2012) Human Dedifferentiated Adipocytes Show Similar Properties to Bone Marrow-Derived Mesenchymal Stem Cells. Stem Cells. ;30(5):965-74. doi:10.1002/stem.1067.
Shah, M., George, R. L., Evancho-Chapman, M. M., & Zhang, G. (2016). Current Challenges in Dedifferentiated Fat Cells Research. Organogenesis, doi:10.1080/15476278.2016.1197461
Anastasia Efimenko, Nina Dzhoyashvili, Natalia Kalinina, Tatiana Kochegura, Renat Akchurin, Vsevolod Tkachuk, Yelena Parfyonova. Adipose-Derived Mesenchymal Stromal Cells From Aged Patients With Coronary Artery Disease Keep Mesenchymal Stromal Cell Properties but Exhibit Characteristics of Aging and Have Impaired Angiogenic Potential (англ.) // Stem Cells Trans Med. — 2014. — Vol. 3184. — P. 32—41. — doi:10.5966/sctm.2013-0014.
Joana Frobe, Hatim Hemeda, Michael Lenz, et al., & Wolfgang Wagneremai (Sept. 2014). Epigenetic Rejuvenation of Mesenchymal Stromal Cells Derived from Induced Pluripotent Stem Cells. Stem Cell Reports, 3(3), 414—422, doi: https://dx.doi.org/10.1016/j.stemcr.2014.07.003
Diederichs Solvig and TuanRocky S. (April, 2014). Functional Comparison of Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Cells and Bone Marrow-Derived Mesenchymal Stromal Cells from the Same Donor Stem Cells and Development. doi:10.1089/scd.2013.0477PMID24625206PMC4086513
Rogers, R. E., Haskell, A., White, B. P., Dalal, S., Lopez, M., Tahan, D., … & Kaunas, R. A scalable system for generation of mesenchymal stem cells derived from induced pluripotent cells employing bioreactors and degradable microcarriers. Stem cells translational medicine. PMID34505405doi:10.1002/sctm.21-0151
Chen Y S, Pelekanos R A., Ellis R L., et al and Nicholas M. Fisk (2012) Small Molecule Mesengenic Induction of Human Induced Pluripotent Stem Cells to Generate Mesenchymal Stem/Stromal Cells Stem Cells Trans Med published online February 7, 2012 doi:10.5966/sctm.2011-0022
Millard, S. M. and Fisk, N. M. (2012), Mesenchymal stem cells for systemic therapy: Shotgun approach or magic bullets?. Bioessays. doi:10.1002/bies.201200087.
Hynes, K., Menicanin, D., Han, J., et al. & Bartold, P. M. (2013). Mesenchymal stem cells from iPS cells facilitate periodontal regeneration. Journal of dental research, 92(9), 833—839.doi:10.1177/0022034513498258
Nguyen, T. D., Chooi, W. H., Jeon, H., Chen, J., Tan, J., Roxby, D. N., ... & Han, J. (2024). Label-Free and High-Throughput Removal of Residual Undifferentiated Cells From iPSC-Derived Spinal Cord Progenitor Cells. Stem Cells Translational Medicine, 13(4), 387-398 PMID38321361PMC11016845doi:10.1093/stcltm/szae002
Kondo, T. (2021). Selective eradication of pluripotent stem cells by inhibiting DHODH activity. Stem cells, 39(1), 33-42. PMID33038285doi:10.1002/stem.3290
Al-Akashi, Z., Zujur, D., Kamiya, D., Kato Jr, T., Kondo, T., & Ikeya, M. (2023). Selective vulnerability of human-induced pluripotent stem cells to dihydroorotate dehydrogenase inhibition during mesenchymal stem/stromal cell purification. Frontiers in Cell and Developmental Biology, 11. 11, 1089945 PMID36814599PMC9939518doi:10.3389/fcell.2023.1089945
Pellegrini, S., Zamarian, V., & Sordi, V. (2022). Strategies to Improve the Safety of iPSC-Derived β Cells for β Cell Replacement in Diabetes. Transplant International, 169. PMID36090777PMC9448870doi:10.3389/ti.2022.10575
Ruenn Chai Lai, Ronne Wee Yeh Yeo, Kok Hian Tan, Sai Kiang Lim (2013) Exosomes for drug delivery — a novel application for the mesenchymal stem cell. Biotechnology Advances.doi:10.1016/j.biotechadv.2012.08.008
Ronne Wee Yeh Yeoa, b, 1, Ruenn Chai Laia, 1, Bin Zhanga, et al. & Sai Kiang Lim (2012)Mesenchymal stem cell: An efficient mass producer of exosomes for drug delivery. Advanced Drug Delivery Reviewsdoi:10.1016/j.addr.2012.07.001
Nobuyoshi Kosaka, Fumitaka Takeshita, Yusuke Yoshioka, et al. & Takahiro Ochiya (2012) Exosomal tumor-suppressive microRNAs as novel cancer therapy: «Exocure» is another choice for cancer treatment. Advanced Drug Delivery Reviewsdoi:10.1016/j.addr.2012.07.011
Dominici, M. L. B. K., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., … & Horwitz, E. M. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4), 315—317. PMID16923606doi:10.1080/14653240600855905
Kaya, H. E. K., & Radhakrishnan, S. K. (2020). Trash Talk: Mammalian Proteasome Regulation at the Transcriptional Level. Trends in Genetics. 37(2), 160—173 PMID32988635PMC7856062doi:10.1016/j.tig.2020.09.005
K. Miyoshi, D. Tsuji, K. Kudoh, et al.& Takafumi Noma (2010) Generation of human induced pluripotent stem cells from oral mucosa J Biosci Bioeng, 110(3), 345—350 doi:10.1016/j.jbiosc.2010.03.004
Katsuhiro Yoshikawa, Motoko Naitoh, Hiroshi Kubota, et al. (2013) Multipotent stem cells are effectively collected from adult human cheek skin. Biochemical and Biophysical Research Communications, 431(1), 104—110 doi:10.1016/j.bbrc.2012.12.069
Hong-Kee Tana, Cheng-Xu Delon Toha, Dongrui Mab, et al. and Yuin-Han Loh (2014). Human Finger-Prick Induced Pluripotent Stem Cells Facilitate the Development of Stem Cell Banking. Stem Cells Trans Med. doi:10.5966/sctm.2013-0195
Ting Zhou, Christina Benda, Sarah Dunzinger, et al. & Miguel A Esteban (2012) Generation of human induced pluripotent stem cells from urine samples. Nature Protocols. 7(12), 2080—2089 doi:10.1038/nprot.2012.115
Shantaram Bharadwaj, Guihua Liu, Yingai Shi, et al. & Yuanyuan Zhang (2013) Multi-Potential Differentiation of Human Urine-Derived Stem Cells: Potential for Therapeutic Applications in Urology. STEM CELLS,31(9), 1840—1856 doi:10.1002/stem.1424
Huang, Y. Z., He, T., Cui, J., Jiang, Y. L., Zeng, J. F., Zhang, W. Q., & Xie, H. Q. (2022). Urine-Derived Stem Cells for Regenerative Medicine: Basic Biology, Applications, and Challenges. Tissue Engineering Part B: Reviews. PMID35049395doi:10.1089/ten.teb.2021.0142
Culenova, M., Nicodemou, A., Novakova, Z. V., Debreova, M., Smolinská, V., Bernatova, S., … & Danisovic, L. (2021). Isolation, Culture and Comprehensive Characterization of Biological Properties of Human Urine-Derived Stem Cells. International Journal of Molecular Sciences, 22(22), 12503. PMID34830384PMC8624597doi:10.3390/ijms222212503
Raab, S., Klingenstein, M., Liebau, S., & Linta, L. (2014). A comparative view on human somatic cell sources for iPSC generation. Stem Cells International, 2014(2014), Article ID 768391, https://dx.doi.org/10.1155/2014/768391
Aija Kyttälä, Roksana Moraghebi, Cristina Valensisi, Johannes Kettunen, Colin Andrus, Kalyan Kumar Pasumarthy, Mahito Nakanishi, Ken Nishimura, Manami Ohtaka, Jere Weltner, Ben Van Handel, Olavi Parkkonen, Juha Sinisalo, Anu Jalanko, R. David Hawkins, Niels-Bjarne Woods, Timo Otonkoski, Ras Trokovic (2016). Genetic Variability Overrides the Impact of Parental Cell Type and Determines iPSC Differentiation Potential. Stem Cell Reports, doi:10.1016/j.stemcr.2015.12.009
Chen, Y., Tristan, C. A., Chen, L., Jovanovic, V. M., Malley, C., Chu, P. H., … & Singeç, I. (2021). A versatile polypharmacology platform promotes cytoprotection and viability of human pluripotent and differentiated cells. Nature Methods, 18(5), 528—541. PMID33941937doi:10.1038/s41592-021-01126-2
Kejin Hu.(March, 2014). Vectorology and factor delivery in induced pluripotent stem cell reprogramming. Stem Cells and Development. doi:10.1089/scd.2013.0621
György, B., Sage, C., Indzhykulian, A. A., Scheffer, D. I., Brisson, A. R., Tan, S., … & Li, Y. (2017). Rescue of Hearing by Gene Delivery to Inner-Ear Hair Cells Using Exosome-Associated AAV. Molecular Therapy. 25(2), 379—391 doi:10.1016/j.ymthe.2016.12.010
Barrett S. D., Bridges A. J., Dudley D. T., Saltiel A. R., Fergus J. H., Flamme C. M., Delaney A. M., Kaufman M., LePage S., Leopold W. R., Przybranowski S. A., Sebolt-Leopold J., Van Becelaere K., Doherty A. M., Kennedy R. M., Marston D., Howard W. A. Jr., Smith Y., Warmus J. S., Tecle H.The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901. (англ.) // Bioorganic & medicinal chemistry letters. — 2008. — Vol. 18, no. 24. — P. 6501—6504. — doi:10.1016/j.bmcl.2008.10.054. — PMID18952427. [исправить]
Gan, T., Fan, L., Zhao, L., Misra, M., Liu, M., Zhang, M., & Su, Y. (2021). JNK Signaling in Drosophila aging and longevity. International Journal of Molecular Sciences, 22(17), 9649. PMID34502551PMC8431792doi:10.3390/ijms22179649
Hirata N., Nakagawa M., Fujibayashi Y., Yamauchi K., Murata A., Minami I., Tomioka M., Kondo T., Kuo T. F., Endo H., Inoue H., Sato S., Ando S., Kawazoe Y., Aiba K., Nagata K., Kawase E., Chang Y. T., Suemori H., Eto K., Nakauchi H., Yamanaka S., Nakatsuji N., Ueda K., Uesugi M.A chemical probe that labels human pluripotent stem cells. (англ.) // Cell reports. — 2014. — Vol. 6, no. 6. — P. 1165—1174. — doi:10.1016/j.celrep.2014.02.006. — PMID24613351. [исправить]
Tanosaki, S., Tohyama, S., Fujita, J., Someya, S., Hishiki, T., Matsuura, T., ... & Fukuda, K. (2020). Fatty acid synthesis is indispensable for survival of human pluripotent stem cells. Iscience, 23(9), 101535. PMID33083764PMC7509212doi:10.1016/j.isci.2020.101535
Nakashima, Y., Miyagi-Shiohira, C., Noguchi, H., & Omasa, T. (2018). Atorvastatin inhibits the HIF1α-PPAR axis, which is essential for maintaining the function of human induced pluripotent stem cells. Molecular Therapy, 26(7), 1715-1734. PMID29929789PMC6036234doi:10.1016/j.ymthe.2018.06.005
Burkert, K., Taheri, H., Hamad, S. et al. (2021). Salicylic diamines selectively eliminate residual undifferentiated cells from pluripotent stem cell-derived cardiomyocyte preparations. Sci Rep 11, 2391 PMC7841182doi:10.1038/s41598-021-81351-z
Qu P, Qing S, Liu R, Qin H, Wang W, Qiao F, et al. (2017) Effects of embryo-derived exosomes on the development of bovine cloned embryos. PLoS ONE12(3): e0174535. https://doi.org/10.1371/journal.pone.0174535
Xu, H., Yang, M., Tian, R. et al. (2020). Derivation and propagation of spermatogonial stem cells from human pluripotent cells. Stem Cell Res Ther 11, 408 https://doi.org/10.1186/s13287-020-01896-0
Yamashiro, C., Sasaki, K., Yokobayashi, S. et al. (2020). Generation of human oogonia from induced pluripotent stem cells in culture. Nat Protoc 15, 1560—1583 https://doi.org/10.1038/s41596-020-0297-5
Lee et al. (2020) Induced pluripotency and spontaneous reversal of cellular aging in supercentenarian donor cells. Biochemical and Biophysical Research Communications. DOI: https://doi.org/10.1016/j.bbrc.2020.02.092
Browder KC, Reddy P, Yamamoto M, et al. (March 2022). "In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice". Nat Aging. doi:10.1038/s43587-022-00183-2.
Kovatcheva, M., Melendez, E., Chondronasiou, D. et al. (2023). Vitamin B12 is a limiting factor for induced cellular plasticity and tissue repair. Nat Metab https://doi.org/10.1038/s42255-023-00916-6
Park, T.S., Zimmerlin, L., Evans-Moses, R. et al. (2020). Vascular progenitors generated from tankyrase inhibitor-regulated naïve diabetic human iPSC potentiate efficient revascularization of ischemic retina. Nat Commun 11, 1195 https://doi.org/10.1038/s41467-020-14764-5
Gatto, N., Dos Santos Souza, C., Shaw, A. C., Bell, S. M., Myszczynska, M. A., Powers, S., … & Azzouz, M. Directly converted astrocytes retain the ageing features of the donor fibroblasts and elucidate the astrocytic contribution to human CNS health and disease. Aging Cell, e13281. https://doi.org/10.1111/acel.13281
So S, Lee Y, Choi J, Kang S, Lee J-Y, Hwang J, et al. (2020) The Rho-associated kinase inhibitor fasudil can replace Y-27632 for use in human pluripotent stem cell research. PLoS ONE 15(5): e0233057. https://doi.org/10.1371/journal.pone.0233057
Yang, P., Li, C., Lee, M., Marzvanyan, A., Zhao, Z. H., Ting, K., … & Zheng, Z. (2020). Photopolymerizable hydrogel encapsulated fibromodulin-reprogrammed cells for muscle regeneration. Tissue engineering. Part A. https://doi.org/10.1089/ten.tea.2020.0026
Bloor, A.J.C., Patel, A., Griffin, J.E. et al. (2020). Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study. Nat Med. https://doi.org/10.1038/s41591-020-1050-x
Soontararak, S., Chow, L., Johnson, V., Coy, J., Wheat, W., Regan, D., & Dow, S. (2018). Mesenchymal Stem Cells (MSC) Derived from Induced Pluripotent Stem Cells (iPSC) Equivalent to Adipose‐Derived MSC in Promoting Intestinal Healing and Microbiome Normalization in Mouse Inflammatory Bowel Disease Model. Stem cells translational medicine. https://doi.org/10.1002/sctm.17-0305
Kim, Y., Jeong, J. & Choi, D. (2020). Small-molecule-mediated reprogramming: a silver lining for regenerative medicine. Exp Mol Med. https://doi.org/10.1038/s12276-020-0383-3
EMD Millipore Application NoteАрхивная копия от 29 октября 2013 на Wayback Machine Min Lu, Cristina Moore, Vi Chu (2011) Enhanced Reprogramming of Human Somatic Cells using Human STEMCCA Polycistronic Lentivirus and Human iPS Cell Boost Supplement
Tachibana M., Amato P., Sparman M., Gutierrez N. M., Tippner-Hedges R., Ma H., Kang E., Fulati A., Lee H. S., Sritanaudomchai H., Masterson K., Larson J., Eaton D., Sadler-Fredd K., Battaglia D., Lee D., Wu D., Jensen J., Patton P., Gokhale S., Stouffer R. L., Wolf D., Mitalipov S.Human embryonic stem cells derived by somatic cell nuclear transfer. (англ.) // Cell. — 2013. — Vol. 153, no. 6. — P. 1228—1238. — doi:10.1016/j.cell.2013.05.006. — PMID23683578. [исправить]
Wang, X., Qu, J., Li, J., He, H., Liu, Z., & Huan, Y. (2020). Epigenetic Reprogramming During Somatic Cell Nuclear Transfer: Recent Progress and Future Directions. Frontiers in Genetics, 11, 205. doi:10.3389/fgene.2020.00205PMC7093498
Malin, K., Witkowska-Piłaszewicz, O., & Papis, K. (2022). The many problems of somatic cell nuclear transfer in reproductive cloning of mammals. Theriogenology, 189, 246-254. PMID35809358doi:10.1016/j.theriogenology.2022.06.030
Hamazaki, N., Kyogoku, H., Araki, H. et al. (2020). Reconstitution of the oocyte transcriptional network with transcription factors. Nature 589(7841):264-269 PMID33328630doi:10.1038/s41586-020-3027-9
Mintz B., Cronmiller C., Custer R. P.Somatic cell origin of teratocarcinomas. (англ.) // Proceedings of the National Academy of Sciences of the United States of America. — 1978. — Vol. 75, no. 6. — P. 2834—2838. — PMID275854. [исправить]
Kunitomi, A., Hirohata, R., Osawa, M., Washizu, K., Arreola, V., Saiki, N., ... & Yamanaka, S. (2024). H1FOO-DD promotes efficiency and uniformity in reprogramming to naive pluripotency. Stem Cell Reports. PMID38701780doi:10.1016/j.stemcr.2024.04.005
Boyer, L. A., Lee, T. I., Cole, M. F., Johnstone, S. E., Levine, S. S., Zucker, J. P., … & Young, R. A. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. cell, 122(6), 947—956. PMID16153702PMC3006442 {{DOI: 10.1016/j.cell.2005.08.020}}
Zhang, J., Tian, X., Peng, C., Yan, C., Li, Y., Sun, M., … & Han, Y. (2018). Transplantation of CREG modified embryonic stem cells improves cardiac function after myocardial infarction in mice. Biochemical and biophysical research communications, 503(2), 482—489. doi:10.1016/j.bbrc.2018.04.160PMID29684345
Shibata, H., Komura, S., Yamada, Y., Sankoda, N., Tanaka, A., Ukai, T., … & Yamada, Y. (2018). In vivo reprogramming drives Kras-induced cancer development. Nature communications, 9(1), 1-16. PMID29802314PMC5970190doi:10.1038/s41467-018-04449-5
Ocampo, A., Reddy, P., Martinez-Redondo, P., Platero-Luengo, A., Hatanaka, F., Hishida, T., … & Belmonte, J. C. I. (2016). In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell, 167(7), 1719—1733. PMID27984723PMC5679279doi:10.1016/j.cell.2016.11.052
Grigorash B.B, van Essen D, Liang G, Grosse L, Emelyanov A, Kang Z, Korablev A, Kanzler B, Molina C, Lopez E, Demidov O.N, Garrido C, Liu F, Saccani S, Bulavin D.V. (2023). p16High senescence restricts cellular plasticity during somatic cell reprogramming. Nat Cell Biol. PMID37652981doi:10.1038/s41556-023-01214-9
Olova, N., Simpson, D. J., Marioni, R. E., & Chandra, T. (2019). Partial reprogramming induces a steady decline in epigenetic age before loss of somatic identity. Aging cell, 18(1), e12877. PMID30450724PMC6351826doi:10.1111/acel.12877
Melendez, E., Chondronasiou, D., Mosteiro, L., Martínez de Villarreal, J., Fernández-Alfara, M., Lynch, C. J., … & Serrano, M. (2022). Natural killer cells act as an extrinsic barrier for in vivo reprogramming. Development, 149(8), dev200361. PMID35420133doi:10.1242/dev.200361
Kamaraj, U. S., Chen, J., Katwadi, K., Ouyang, J. F., Sun, Y. B. Y., Lim, Y. M., … & Rackham, O. J. (2020). EpiMogrify models H3K4me3 data to identify signaling molecules that improve cell fate control and maintenance. Cell Systems, 11(5), 509—522. PMID33038298doi:10.1016/j.cels.2020.09.004
Rukhlenko, O. S., Halasz, M., Rauch, N., Zhernovkov, V., Prince, T., Wynne, K., … & Kholodenko, B. N. (2022). Control of cell state transitions. Nature, 1-11. PMID36104561doi:10.1038/s41586-022-05194-y
Joung, J., Ma, S., Tay, T., Geiger-Schuller, K. R., Kirchgatterer, P. C., Verdine, V. K., ... & Zhang, F. (2023). A transcription factor atlas of directed differentiation. Cell, 186(1), 209-229. PMID36608654doi:10.1016/j.cell.2022.11.026
Koga, K., Wang, B., & Kaneko, S. (2020). Current status and future perspectives of HLA-edited induced pluripotent stem cells. Inflammation and Regeneration, 40(1), 23-29. doi:10.1186/s41232-020-00132-9PMC7528263PMID33014207
Di Stasi A., Tey S. K., Dotti G., Fujita Y., Kennedy-Nasser A., Martinez C., Straathof K., Liu E., Durett A. G., Grilley B., Liu H., Cruz C. R., Savoldo B., Gee A. P., Schindler J., Krance R. A., Heslop H. E., Spencer D. M., Rooney C. M., Brenner M. K.Inducible apoptosis as a safety switch for adoptive cell therapy. (англ.) // The New England journal of medicine. — 2011. — Vol. 365, no. 18. — P. 1673—1683. — doi:10.1056/NEJMoa1106152. — PMID22047558. [исправить]
Shi, Z. D., Tchao, J., Wu, L., & Carman, A. J. Precision installation of a highly efficient suicide gene safety switch in human induced pluripotent stem cells. Stem cells translational medicine. PMID32662231doi:10.1002/sctm.20-0007
Vidal, S. E., Polyzos, A., Chatterjee, K., Ee, L. S., Swanzey, E., Morales-Valencia, J., … & Stadtfeld, M. (2020). Context-dependent requirement of euchromatic histone methyltransferase activity during reprogramming to pluripotency. Stem cell reports, 15(6), 1233—1245. PMID32976761PMC7724475doi:10.1016/j.stemcr.2020.08.011
Deng, P., Yuan, Q., Cheng, Y., Li, J., Liu, Z., Liu, Y., … & Wang, C. Y. (2021). Loss of KDM4B exacerbates bone-fat imbalance and mesenchymal stromal cell exhaustion in skeletal aging. Cell Stem Cell. S1934-5909(21)00010-2 PMID33571444doi:10.1016/j.stem.2021.01.010
Wei J, Antony J, Meng F, MacLean P, Rhind R, Laible G, Oback B (2017) KDM4B‐mediated reduction of H3K9me3 and H3K36me3 levels improves somatic cell reprogramming into pluripotency. Sci Rep 7: 7514 PMID28790329PMC5548918doi:10.1038/s41598-017-06569-2
Cheloufi S., Elling U., Hopfgartner B., Jung Y. L., Murn J., Ninova M., Hubmann M., Badeaux A. I., Euong Ang C., Tenen D., Wesche D. J., Abazova N., Hogue M., Tasdemir N., Brumbaugh J., Rathert P., Jude J., Ferrari F., Blanco A., Fellner M., Wenzel D., Zinner M., Vidal S. E., Bell O., Stadtfeld M., Chang H. Y., Almouzni G., Lowe S. W., Rinn J., Wernig M., Aravin A., Shi Y., Park P. J., Penninger J. M., Zuber J., Hochedlinger K.The histone chaperone CAF-1 safeguards somatic cell identity. (англ.) // Nature. — 2015. — Vol. 528, no. 7581. — P. 218—224. — doi:10.1038/nature15749. — PMID26659182. [исправить]
Rais Y., Zviran A., Geula S., Gafni O., Chomsky E., Viukov S., Mansour A. A., Caspi I., Krupalnik V., Zerbib M., Maza I., Mor N., Baran D., Weinberger L., Jaitin D. A., Lara-Astiaso D., Blecher-Gonen R., Shipony Z., Mukamel Z., Hagai T., Gilad S., Amann-Zalcenstein D., Tanay A., Amit I., Novershtern N., Hanna J. H.Deterministic direct reprogramming of somatic cells to pluripotency. (англ.) // Nature. — 2013. — Vol. 502, no. 7469. — P. 65—70. — doi:10.1038/nature12587. — PMID24048479. [исправить]
Hu, X., Wu, Q., Zhang, J., Kim, J., Chen, X., Hartman, A. A., … & Guo, S. (2021). Reprogramming progressive cells display low CAG promoter activity. STEM CELLS, 39(1), 43-54. PMID33075202PMC7821215doi:10.1002/stem.3295
Esteban, M. A., Wang, T., Qin, B., Yang, J., Qin, D., Cai, J., ... & Pei, D. (2010). Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell stem cell, 6(1), 71-79. PMID20036631doi:10.1016/j.stem.2009.12.001
Pavlovic, V., Ciric, M., Petkovic, M., & Golubovic, M. (2023). Vitamin C and epigenetics: A short physiological overview. Open Medicine, 18(1), 20230688. ((PMID|37359134}} PMC10290282doi:10.1515/med-2023-0688
Zimmerlin, L., Park, T. S., Huo, J. S., Verma, K., Pather, S. R., Talbot, C. C., … & Guo, H. (2016). Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality. Development, 143(23), 4368-4380. doi:10.1242/dev.138982PMC5201042
Eva Szabo, et al & Mickie Bhatia (2010) Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 468, 521—526 PMID21057492doi:10.1038/nature09591
Jem A. Efe, et al & Sheng Ding (2011) Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy Nature Cell Biology 13, 215—222 PMID21278734doi:10.1038/ncb2164
Han D.W., Tapia N., Hermann A., et al. & Schöler H.R. Direct Reprogramming of Fibroblasts into Neural Stem Cells by Defined Factors.Stem Cells Dev. 2012 Mar 1;21(4):521-9. PMID22445517doi:10.1016/j.stem.2012.02.021
Horisawa, K., & Suzuki, A. (2020). Direct cell-fate conversion of somatic cells: Toward regenerative medicine and industries. Proceedings of the Japan Academy. Series B, Physical and Biological Sciences, 96(4), 131—158. doi:10.2183/pjab.96.012PMC7247973PMID32281550
Zheng, Z., Jian, J., Zhang, X., Zara, J. N., Yin, W., Chiang, M., … & Soo, C. (2012). Reprogramming of human fibroblasts into multipotent cells with a single ECM proteoglycan, fibromodulin. Biomaterials, 33(24), 5821-5831. PMID22622142doi:10.1016/j.biomaterials.2012.04.049
Zheng, Z., Li, C., Ha, P., Chang, G. X., Yang, P., Zhang, X., … & Mills, Z. (2019). CDKN2B upregulation prevents teratoma formation in multipotent fibromodulin-reprogrammed cells. Journal of Clinical Investigation, 129(8), 3236-3251. doi:10.1172/JCI125015PMC6668700PMID31305260
Roy, B., Yuan, L., Lee, Y., Bharti, A., Mitra, A., & Shivashankar, G. V. (2020). Fibroblast rejuvenation by mechanical reprogramming and redifferentiation. Proceedings of the National Academy of Sciences, 117(19), 10131-10141 doi:10.1073/pnas.1911497117PMC7229653PMID32350144
Pushp, P., Nogueira, D. E., Rodrigues, C. A., Ferreira, F. C., Cabral, J. M., & Gupta, M. K. (2020). A Concise Review on Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Personalized Regenerative Medicine. Stem Cell Reviews and Reports, 1-29. PMID33098306doi:10.1007/s12015-020-10061-22
Suzuki, D., Flahou, C., Yoshikawa, N., Stirblyte, I., Hayashi, Y., Sawaguchi, A., … & Matsumoto, T. (2020). «iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity». Stem cell reports, 14(1), 49-59. doi:10.1016/j.stemcr.2019.11.011PMC6962657PMID31883921
Diederichs Solvig and TuanRocky S. (April, 2014). Functional Comparison of Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Cells and Bone Marrow-Derived Mesenchymal Stromal Cells from the Same Donor Stem Cells and Development. doi:10.1089/scd.2013.0477PMID24625206PMC4086513
Rogers, R. E., Haskell, A., White, B. P., Dalal, S., Lopez, M., Tahan, D., … & Kaunas, R. A scalable system for generation of mesenchymal stem cells derived from induced pluripotent cells employing bioreactors and degradable microcarriers. Stem cells translational medicine. PMID34505405doi:10.1002/sctm.21-0151
Nguyen, T. D., Chooi, W. H., Jeon, H., Chen, J., Tan, J., Roxby, D. N., ... & Han, J. (2024). Label-Free and High-Throughput Removal of Residual Undifferentiated Cells From iPSC-Derived Spinal Cord Progenitor Cells. Stem Cells Translational Medicine, 13(4), 387-398 PMID38321361PMC11016845doi:10.1093/stcltm/szae002
Kondo, T. (2021). Selective eradication of pluripotent stem cells by inhibiting DHODH activity. Stem cells, 39(1), 33-42. PMID33038285doi:10.1002/stem.3290
Al-Akashi, Z., Zujur, D., Kamiya, D., Kato Jr, T., Kondo, T., & Ikeya, M. (2023). Selective vulnerability of human-induced pluripotent stem cells to dihydroorotate dehydrogenase inhibition during mesenchymal stem/stromal cell purification. Frontiers in Cell and Developmental Biology, 11. 11, 1089945 PMID36814599PMC9939518doi:10.3389/fcell.2023.1089945
Pellegrini, S., Zamarian, V., & Sordi, V. (2022). Strategies to Improve the Safety of iPSC-Derived β Cells for β Cell Replacement in Diabetes. Transplant International, 169. PMID36090777PMC9448870doi:10.3389/ti.2022.10575
Dominici, M. L. B. K., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., … & Horwitz, E. M. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4), 315—317. PMID16923606doi:10.1080/14653240600855905
Kaya, H. E. K., & Radhakrishnan, S. K. (2020). Trash Talk: Mammalian Proteasome Regulation at the Transcriptional Level. Trends in Genetics. 37(2), 160—173 PMID32988635PMC7856062doi:10.1016/j.tig.2020.09.005
Huang, Y. Z., He, T., Cui, J., Jiang, Y. L., Zeng, J. F., Zhang, W. Q., & Xie, H. Q. (2022). Urine-Derived Stem Cells for Regenerative Medicine: Basic Biology, Applications, and Challenges. Tissue Engineering Part B: Reviews. PMID35049395doi:10.1089/ten.teb.2021.0142
Culenova, M., Nicodemou, A., Novakova, Z. V., Debreova, M., Smolinská, V., Bernatova, S., … & Danisovic, L. (2021). Isolation, Culture and Comprehensive Characterization of Biological Properties of Human Urine-Derived Stem Cells. International Journal of Molecular Sciences, 22(22), 12503. PMID34830384PMC8624597doi:10.3390/ijms222212503
Chen, Y., Tristan, C. A., Chen, L., Jovanovic, V. M., Malley, C., Chu, P. H., … & Singeç, I. (2021). A versatile polypharmacology platform promotes cytoprotection and viability of human pluripotent and differentiated cells. Nature Methods, 18(5), 528—541. PMID33941937doi:10.1038/s41592-021-01126-2
Barrett S. D., Bridges A. J., Dudley D. T., Saltiel A. R., Fergus J. H., Flamme C. M., Delaney A. M., Kaufman M., LePage S., Leopold W. R., Przybranowski S. A., Sebolt-Leopold J., Van Becelaere K., Doherty A. M., Kennedy R. M., Marston D., Howard W. A. Jr., Smith Y., Warmus J. S., Tecle H.The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901. (англ.) // Bioorganic & medicinal chemistry letters. — 2008. — Vol. 18, no. 24. — P. 6501—6504. — doi:10.1016/j.bmcl.2008.10.054. — PMID18952427. [исправить]
Gan, T., Fan, L., Zhao, L., Misra, M., Liu, M., Zhang, M., & Su, Y. (2021). JNK Signaling in Drosophila aging and longevity. International Journal of Molecular Sciences, 22(17), 9649. PMID34502551PMC8431792doi:10.3390/ijms22179649
Hirata N., Nakagawa M., Fujibayashi Y., Yamauchi K., Murata A., Minami I., Tomioka M., Kondo T., Kuo T. F., Endo H., Inoue H., Sato S., Ando S., Kawazoe Y., Aiba K., Nagata K., Kawase E., Chang Y. T., Suemori H., Eto K., Nakauchi H., Yamanaka S., Nakatsuji N., Ueda K., Uesugi M.A chemical probe that labels human pluripotent stem cells. (англ.) // Cell reports. — 2014. — Vol. 6, no. 6. — P. 1165—1174. — doi:10.1016/j.celrep.2014.02.006. — PMID24613351. [исправить]
Tanosaki, S., Tohyama, S., Fujita, J., Someya, S., Hishiki, T., Matsuura, T., ... & Fukuda, K. (2020). Fatty acid synthesis is indispensable for survival of human pluripotent stem cells. Iscience, 23(9), 101535. PMID33083764PMC7509212doi:10.1016/j.isci.2020.101535
Nakashima, Y., Miyagi-Shiohira, C., Noguchi, H., & Omasa, T. (2018). Atorvastatin inhibits the HIF1α-PPAR axis, which is essential for maintaining the function of human induced pluripotent stem cells. Molecular Therapy, 26(7), 1715-1734. PMID29929789PMC6036234doi:10.1016/j.ymthe.2018.06.005
Burkert, K., Taheri, H., Hamad, S. et al. (2021). Salicylic diamines selectively eliminate residual undifferentiated cells from pluripotent stem cell-derived cardiomyocyte preparations. Sci Rep 11, 2391 PMC7841182doi:10.1038/s41598-021-81351-z
Hiew, Y.-L. (2011)Архивная копия от 23 октября 2013 на Wayback Machine Examining the biological consequences of DNA damage caused by irradiated J2-3T3 fibroblast feeder cells and HPV16: characterisation of the biological functions of Mll. Doctoral thesis, UCL (University College London)
Hiew, Y.-L. (2011)Архивная копия от 23 октября 2013 на Wayback Machine Examining the biological consequences of DNA damage caused by irradiated J2-3T3 fibroblast feeder cells and HPV16: characterisation of the biological functions of Mll. Doctoral thesis, UCL (University College London)
EMD Millipore Application NoteАрхивная копия от 29 октября 2013 на Wayback Machine Min Lu, Cristina Moore, Vi Chu (2011) Enhanced Reprogramming of Human Somatic Cells using Human STEMCCA Polycistronic Lentivirus and Human iPS Cell Boost Supplement
Tachibana M., Amato P., Sparman M., Gutierrez N. M., Tippner-Hedges R., Ma H., Kang E., Fulati A., Lee H. S., Sritanaudomchai H., Masterson K., Larson J., Eaton D., Sadler-Fredd K., Battaglia D., Lee D., Wu D., Jensen J., Patton P., Gokhale S., Stouffer R. L., Wolf D., Mitalipov S.Human embryonic stem cells derived by somatic cell nuclear transfer. (англ.) // Cell. — 2013. — Vol. 153, no. 6. — P. 1228—1238. — doi:10.1016/j.cell.2013.05.006. — PMID23683578. [исправить]
Mintz B., Cronmiller C., Custer R. P.Somatic cell origin of teratocarcinomas. (англ.) // Proceedings of the National Academy of Sciences of the United States of America. — 1978. — Vol. 75, no. 6. — P. 2834—2838. — PMID275854. [исправить]
Di Stasi A., Tey S. K., Dotti G., Fujita Y., Kennedy-Nasser A., Martinez C., Straathof K., Liu E., Durett A. G., Grilley B., Liu H., Cruz C. R., Savoldo B., Gee A. P., Schindler J., Krance R. A., Heslop H. E., Spencer D. M., Rooney C. M., Brenner M. K.Inducible apoptosis as a safety switch for adoptive cell therapy. (англ.) // The New England journal of medicine. — 2011. — Vol. 365, no. 18. — P. 1673—1683. — doi:10.1056/NEJMoa1106152. — PMID22047558. [исправить]
Cheloufi S., Elling U., Hopfgartner B., Jung Y. L., Murn J., Ninova M., Hubmann M., Badeaux A. I., Euong Ang C., Tenen D., Wesche D. J., Abazova N., Hogue M., Tasdemir N., Brumbaugh J., Rathert P., Jude J., Ferrari F., Blanco A., Fellner M., Wenzel D., Zinner M., Vidal S. E., Bell O., Stadtfeld M., Chang H. Y., Almouzni G., Lowe S. W., Rinn J., Wernig M., Aravin A., Shi Y., Park P. J., Penninger J. M., Zuber J., Hochedlinger K.The histone chaperone CAF-1 safeguards somatic cell identity. (англ.) // Nature. — 2015. — Vol. 528, no. 7581. — P. 218—224. — doi:10.1038/nature15749. — PMID26659182. [исправить]
Rais Y., Zviran A., Geula S., Gafni O., Chomsky E., Viukov S., Mansour A. A., Caspi I., Krupalnik V., Zerbib M., Maza I., Mor N., Baran D., Weinberger L., Jaitin D. A., Lara-Astiaso D., Blecher-Gonen R., Shipony Z., Mukamel Z., Hagai T., Gilad S., Amann-Zalcenstein D., Tanay A., Amit I., Novershtern N., Hanna J. H.Deterministic direct reprogramming of somatic cells to pluripotency. (англ.) // Nature. — 2013. — Vol. 502, no. 7469. — P. 65—70. — doi:10.1038/nature12587. — PMID24048479. [исправить]
Barrett S. D., Bridges A. J., Dudley D. T., Saltiel A. R., Fergus J. H., Flamme C. M., Delaney A. M., Kaufman M., LePage S., Leopold W. R., Przybranowski S. A., Sebolt-Leopold J., Van Becelaere K., Doherty A. M., Kennedy R. M., Marston D., Howard W. A. Jr., Smith Y., Warmus J. S., Tecle H.The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901. (англ.) // Bioorganic & medicinal chemistry letters. — 2008. — Vol. 18, no. 24. — P. 6501—6504. — doi:10.1016/j.bmcl.2008.10.054. — PMID18952427. [исправить]
Hirata N., Nakagawa M., Fujibayashi Y., Yamauchi K., Murata A., Minami I., Tomioka M., Kondo T., Kuo T. F., Endo H., Inoue H., Sato S., Ando S., Kawazoe Y., Aiba K., Nagata K., Kawase E., Chang Y. T., Suemori H., Eto K., Nakauchi H., Yamanaka S., Nakatsuji N., Ueda K., Uesugi M.A chemical probe that labels human pluripotent stem cells. (англ.) // Cell reports. — 2014. — Vol. 6, no. 6. — P. 1165—1174. — doi:10.1016/j.celrep.2014.02.006. — PMID24613351. [исправить]
